Eddy Sotelo

25PUBLICATIONS
69CO-AUTHORS
Biologically active moleculesCell physiologyProteomics and intermolecular interactions (excl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 31, 2026
Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes.

|Oct 27, 2026
N-Adamantyl-1-Pentyl-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide and N-(Adamantan-1-Yl)-2-(Alkyloxy)benzamide Derivatives as Fluorescent Probes for Selective CB2R Targeting.

|Oct 23, 2026
From Structurally Diverse Sigma-1 (σ1) Receptor Reference Ligands to Live-Cell Probes: Fluorescent Phenoxyalkylpiperidines for the Detection of σ1 Receptor.

|Sep 26, 2026
Bridging E3 Ligase Binding and Targeted Degradation Through Fluorescence Polarization.

|Sep 19, 2025
Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.

Gemma Navarro, Iu Raïch, Joan Biel Rebassa

|Aug 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz

Pageof 5

Frequent Collaborators

10 joint publications

Hugo Gutiérrez-de-Terán

9 joint publications

Rubén Prieto-Díaz

9 joint publications

Marialessandra Contino

9 joint publications

Angela Stefanachi